In the BioHarmony Drug Report Database
Atrasentan
Atrasentan is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against endothelin-1 receptor. In addition, it is known to target endothelin receptor type B.
Trade Name
|
|
|---|---|
Common Name
|
atrasentan |
ChEMBL ID
|
CHEMBL9194 |
Indication
|
|
Drug Class
|
Endothelin receptor antagonists |
Image (chem structure or protein)